Canada-Based Switch Health Launches At-Home HPV Test September 27, 2023 Canada-based Switch Health has unveiled the countrys first-of-its-kind at-home HPV (human papillomavirus) testing kit. This kit allows for convenient and regular HPV testing from the privacy of one's own home.
Adela Health Raises $48Mn Funding to Boost Cancer Detection Technologies September 27, 2023 California-based Adela Health, a healthcare startup specialising in blood testing for minimal residual disease monitoring and early cancer detection, has secured $48 million in financing.
Cigna Faces Growing Legal Lawsuits Following Claims of Automated Denials September 26, 2023 Cigna Group is grappling with a surge in lawsuits from both members and shareholders after a ProPublica report alleged the denial of members' claims en masse without individual evaluation, thereby withholding coverage for certain services.
Germany-Based Merck Enters Two Strategic Collaborations to Strengthen AI-Driven Drug Discovery September 22, 2023 Germanys prominent science and technology player, Merck has entered into two strategic drug discovery collaborations with BenevolentAI, London, UK, and Exscientia, Oxford, UK.
Vori Health and Ophelia Join Hands for Effective Pain Management September 22, 2023 New York-based Ophelia, an opioid use disorder (OUD) treatment provider, has partnered with Nashville-based Vori Health, a musculoskeletal (MSK) focused care provider.
Abbott Partners Spain-Based mAbxience to Commercialise Biosimilars in Emerging Markets September 22, 2023 This collaborative move will help introduce life-saving treatments in key oncology, women's health and respiratory diseases for the first time in some countries at a fraction of the cost of originator biologics.
Chicago-Based Vivante Health Secures $31M in Series B Funding September 22, 2023 The latest funding round brings the total capital raised by Vivante to date to $47M, following a $16M Series A round in late 2021.
California-Based Equip Health Expands Eating Disorder Treatment Services for Adults in the US September 21, 2023 This move aims to address a crucial gap in the healthcare landscape, ensuring that more individuals grappling with eating disorders can access essential care.
AstraZeneca's Rare Disease Unit Buys Pfizer Portfolio September 20, 2023 The global pharma giant AstraZeneca's rare disease unit Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.
US Department of Defense & Google Collaborates to Make Smart Microscope to Detect Cancer September 20, 2023 The Department of Defense (DoD) has collaborated with Google to develop a smart microscope called Augmented Reality Microscope (ARM) that utilises AI to aid doctors in identifying different types of cancer.
Google DeepMind Unveils AI Tool to Predict Harmful Genetic Mutations September 20, 2023 A study published in the journal 'Science' revealed that the AI tool accurately predicted 89% of these mutations with a 90% precision rate. Each mutation was assigned a score indicating its potential to induce disease, termed 'pathogenic.'
ClosedLoop Introduces Tools to Anticipate Risks and Assess Population Health Program Impact September 20, 2023 US-based ClosedLoop, a healthcare data science platform, has recently unveiled two new offerings aimed at aiding healthcare organisations in assessing and guiding the real-world effectiveness of their healthcare initiatives.